Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$595K Buy
32,053
+2,511
+8% +$50K 0.04% 393
2026
Q1
$556K Buy
29,542
+10,768
+57% +$202K 0.04% 357
2025
Q4
$293K Buy
18,774
+5,877
+46% +$87.2K 0.02% 526
2025
Q3
$171K Buy
+12,897
New +$167K 0.01% 675

Other funds holding NOV

Transcend Capital Advisors's NOV Position: Q2 2026 in Review

Transcend Capital Advisors increased its NOV (NOV) stake by 8.5% in Q2 2026, buying an estimated $50K and bringing the position to 32,053 shares worth $595K. The position accounts for 0.04% of the portfolio, ranked #393.

Transcend Capital Advisors first reported a position in NOV in Q3 2025 and has held it in 4 quarters since. 489 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Transcend Capital Advisors held 32,053 shares of NOV worth $595K as of Q2 2026.
  • Transcend Capital Advisors bought 2,511 NOV shares in Q2 2026, an estimated $50K.
  • NOV made up 0.04% of Transcend Capital Advisors's portfolio in Q2 2026, its #393 holding.
  • Transcend Capital Advisors first reported a position in NOV in Q3 2025 and has held it in 4 quarters since.
  • 489 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.